Contact us:
+1 (520) 226-8615
Email:
[email protected]
IHP 310-Drug Development and Ethical Considerations
IHP 310-Drug Development and Ethical Considerations Chapter 01
McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 9th Edition
MULTIPLE CHOICE
- The nurse is obtaining consent from a subject newly recruited for a clinical drug trial that will last for 6 months. All subjects will be given gift certificates for participating. One subject says, “Well, I guess if the drug doesn’t work, I’ll just have to put up with the symptoms for 6 months.” What will the nurse tell the subject?
| a. | “Participation for the duration of the study is required.” |
| b. | “Participation may end at any time without penalty.” |
| c. | “Withdrawal from the study may end at any time, but the gift certificate will not be given.” |
| d. | “You can request placement in the treatment group.” |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 3
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management of Client Care
- The nurse is assisting with a clinical drug trial in which the side effects of two effective drugs are being compared. A patient who would benefit from either drug has elected to withdraw from the study, and the nurse assists with the paperwork to facilitate this. This is an example of
| a. | autonomy. |
| b. | beneficence. |
| c. | justice. |
| d. | veracity. |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 3
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
- During a clinical drug trial for a new medication, researchers note a previously unknown serious adverse effect occurring in more than 50% of subjects. The study is discontinued. Which ethical principle is being exercised?
| a. | Beneficence |
| b. | Justice |
| c. | Respect for persons |
| d. | Veracity |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 4
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
- In a 5-year experimental clinical trial to investigate a new cancer treatment, researchers in the second year note overwhelming improvement in almost all of the subjects in the treatment group. The lead researcher elects to continue the study. Which ethical principle is being violated?
| a. | Beneficence |
| b. | Justice |
| c. | Respect for persons |
| d. | Veracity |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 4
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
IHP 310-Drug Development and Ethical Considerations
- The nurse is enrolling subjects for a double-blind experimental study. One patient asks the nurse to explain the role of the experimental group. The nurse will explain that subjects in the experimental group in this type of study
| a. | are selected for participation in that group. |
| b. | have unique baseline characteristics. |
| c. | receive a placebo. |
| d. | receive the treatment being evaluated. |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 6
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
- The nurse is obtaining signatures on consent forms for participation in a clinical drug trial. One patient says, “I’m not sure I want to do this, but I need the cash.” The nurse will take which action?
| a. | Ask the patient to clarify concerns. |
| b. | Reinforce that cash is given to all subjects equally. |
| c. | Report this statement to the party named on the consent. |
| d. | Review the elements of the study and obtain consent. |
ANS:
DIF: Cognitive Level: Applying (Application) REF: p. 3
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management of Client Care
- Which is the characteristic of preclinical in vivo testing?
| a. | A comparison of experimental and control data in animals |
| b. | A study conducted in a test tube in a laboratory |
| c. | A study that determines the effects of the placebo in human participants |
| d. | A study to assess the seriousness of the disease to be treated |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 4
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
- Many drugs marketed in the 1980s may not be effective in a majority of the population. The nurse understands that this is because these drugs
| a. | did not pass through the appropriate phases of clinical trials. |
| b. | did not require human subject protections and are invalid. |
| c. | were not tested on women, minorities, or children. |
| d. | were tested on healthy subjects only. |
ANS: C
Drug research was historically done only with Caucasian males, causing uncertainty as to the validity of the research results.
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 4
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
- The nurse is assisting with data collection in a study of drug effects in healthy subjects. The nurse assists with blood and urine collection to determine serum drug levels and the presence of metabolites in the urine. Which phase of a drug study does this represent?
| a. | Phase I |
| b. | Phase II |
| c. | Phase III |
| d. | Phase IV |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 4
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
IHP 310-Drug Development and Ethical Considerations
- The nurse is enrolling subjects for a clinical drug trial in which subjects will be randomly assigned to either a treatment or a placebo group. The pills in both groups will be in identical packaging with identical appearance. The group that receives the intervention is the
| a. | control group. |
| b. | experimental group. |
| c. | dependent group. |
| d. | independent group. |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 6
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
- The nurse is assisting with a clinical drug trial to test the safe dose of an analgesic medication and learns that subjects have been told that the study is about measuring the analgesic effects. Which ethical principle has been violated?
| a. | Beneficence |
| b. | Justice |
| c. | Respect for persons |
| d. | Veracity |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 3
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
- A clinical drug trial is concluding a study of pharmacokinetics and safety of a drug in healthy individuals. The nurse will assist enrollment of participants into the next phase of the study and will include which subjects?
| a. | Healthy subjects |
| b. | Healthy and ill subjects |
| c. | Subjects with the disease the drug will treat |
| d. | Subjects with other diseases |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 6
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management of Client Care
- Before marketing a new drug that has been approved for use based on clinical effectiveness and safety, the manufacturer wishes to study the potential new uses for the drug. This is an example of which phase of study?
| a. | Phase I |
| b. | Phase II |
| c. | Phase III |
| d. | Phase IV |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 4
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
ORDER NOW FOR A CUSTOM-WRITTEN, PLAGIARISM-FREE PAPER WITH ALL INSTRUCTIONS FOLLOWED
- Which statement about the safety and efficacy of medications in children is accurate?
| a. | Children cannot give consent, so clinical drug trials are not performed on children. |
| b. | Children can only be subjects in quasi-experimental clinical studies. |
| c. | Data from adult clinical drug trials can be extrapolated to children. |
| d. | Federal law requires that drugs for children be tested on children. |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 8
TOP: Nursing Process: N/A MSC: NCLEX: Management of Client Care
IHP 310-Drug Development and Ethical Considerations
- The nurse is preparing to administer a schedule II injectable drug and is drawing up half of the contents of a single-use vial. Which nursing action is correct?
| a. | Ask another nurse to observe and cosign wasting the remaining drug from the vial. |
| b. | Keep the remaining amount in the patient’s drawer to give at the next dose. |
| c. | Record the amount unused in the patient’s medication record. |
| d. | Dispose of the vial with the remaining drug into a locked collection box. |
ANS:
DIF: Cognitive Level: Applying (Application) REF: p. 8
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- A patient is prescribed a medication and asks the nurse if the drug is available in a generic form. The nurse understands that a generic medication will have a name that
| a. | is a registered trademark. |
| b. | is always capitalized. |
| c. | is related to the drug’s chemical structure. |
| d. | is nonproprietary. |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 11
TOP: Nursing Process: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- A patient receives a prescription on which the provider has noted that a generic medication may be given. The patient asks the nurse what this means. What will the nurse tell the patient about generic drugs?
| a. | They contain the same inert ingredients as brand-name drugs. |
| b. | They have chemical structures that are identical to proprietary drugs. |
| c. | They tend to be less expensive than brand-name drugs. |
| d. | They undergo extensive testing before they are marketed. |
ANS:
DIF: Cognitive Level: Applying (Application) REF: p. 11
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
- The nurse reviews information about a drug and notes the initials “United States Pharmacopeia (USP)” after the drug’s official name. The nurse understands that this designation indicates the drug
| a. | is a controlled substance. |
| b. | is approved by the FDA. |
| c. | is available in generic form. |
| d. | meets quality and safety standards. |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 7
TOP: Nursing Process: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- The nurse is preparing to give a medication to a child. The child’s parent asks whether the drug is safe for children. How will the nurse respond to the parent?
| a. | “Drugs are tested on adults and safe doses for children are based on weights compared to adult weights.” |
| b. | “Drugs are deemed safe for children over time when repeated use proves effectiveness and safety.” |
| c. | “Drugs are tested for both efficacy and safety in children in order to be marketed for pediatric use.” |
| d. | “Drugs are tested on children in postmarketing studies and on a limited basis.” |
ANS:
DIF: Cognitive Level: Applying (Application) REF: p. 9
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- Which law(s) govern all drug administration by nurses?
| a. | Drug Regulation and Reform Act |
| b. | FDA Amendments Act |
| c. | Nurse Practice Acts |
| d. | The Controlled Substances Act |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 9
TOP: Nursing Process: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- A patient is taking methadone as part of a heroin withdrawal program. The nurse understands that, in this instance, methadone is classified as which drug schedule?
| a. | C-I |
| b. | C-II |
| c. | C-III |
| d. | C-V |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 9
TOP: Nursing Process: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- The nurse is preparing to administer a combination drug containing acetaminophen and codeine. The nurse knows that this drug is classified as which drug schedule?
| a. | C-II |
| b. | C-III |
| c. | C-IV |
| d. | C-V |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 9
TOP: Nursing Process: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
IHP 310-Drug Development and Ethical Considerations
MULTIPLE RESPONSE
- Which are responsibilities of the FDA? (Select all that apply.)
| a. | To ensure a drug has accurate labeling. |
| b. | To ensure a drug is affordable. |
| c. | To ensure a drug is effective. |
| d. | To ensure a drug is free from adverse reactions. |
| e. | To ensure a drug is tested for harmful effects. |
ANS:
DIF: Cognitive Level: Understanding (Comprehension) REF: pp. 8-9
TOP: Nursing Process: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies